Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)

Core Insights - Roche has introduced an innovative Chest Pain Triage algorithm as part of the navifyⓇ Algorithm Suite, aimed at improving the detection of Acute Coronary Syndrome (ACS) in patients with chest pain, a common reason for Emergency Department visits [1][3][7] Group 1: Algorithm Features - The Chest Pain Triage algorithm utilizes advanced diagnostic technologies, including high-sensitivity cardiac troponin testing, to provide timely and reliable data for differentiating between cardiac and non-cardiac chest pain [2][4] - It incorporates European Society of Cardiology (ESC) guidelines and was developed with input from leading cardiologists and emergency medicine experts [2][4] - The algorithm simplifies decision-making by automatically selecting the appropriate ESC accelerated pathway based on blood sample timing, potentially reducing unnecessary hospital admissions and associated costs [3][4] Group 2: Impact on Emergency Care - The algorithm aims to reduce Emergency Department visit times by over three hours by quickly identifying patients who need urgent cardiac care versus those who can be discharged sooner [3][4] - It includes a medical dossier for clinician support and simplifies documentation, allowing for easy integration into patient records [3][4] Group 3: Availability and Future Developments - The Chest Pain Triage algorithm is currently available in Europe, the Middle East, and Asia, with plans for availability in the United States at a later date [4][5] - Roche's cardiometabolic portfolio will continue to evolve, combining next-generation digital algorithms, biomarkers, near-patient care devices, and laboratory analyzers for enhanced ACS management [4][5]